A detailed history of Bvf Inc transactions in Cytom X Therapeutics, Inc. stock. As of the latest transaction made, Bvf Inc holds 5,228,461 shares of CTMX stock, worth $5.23 Million. This represents 0.2% of its overall portfolio holdings.

Number of Shares
5,228,461
Previous 6,595,801 20.73%
Holding current value
$5.23 Million
Previous $14.4 Million 55.64%
% of portfolio
0.2%
Previous 0.43%

Shares

15 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 14, 2024

SELL
$1.21 - $5.13 $1.65 Million - $7.01 Million
-1,367,340 Reduced 20.73%
5,228,461 $6.38 Million
Q3 2022

Nov 14, 2022

BUY
$1.23 - $1.97 $974,284 - $1.56 Million
792,101 Added 13.65%
6,595,801 $9.56 Million
Q4 2021

Feb 14, 2022

BUY
$3.87 - $7.39 $22.5 Million - $42.9 Million
5,803,700 New
5,803,700 $25.1 Million
Q2 2021

Aug 16, 2021

SELL
$6.33 - $9.91 $35.3 Million - $55.3 Million
-5,576,471 Closed
0 $0
Q4 2020

Feb 12, 2021

BUY
$6.47 - $7.9 $13 Million - $15.9 Million
2,016,749 Added 56.65%
5,576,471 $36.5 Million
Q3 2020

Nov 13, 2020

BUY
$6.55 - $8.83 $2.91 Million - $3.92 Million
444,185 Added 14.26%
3,559,722 $23.7 Million
Q2 2020

Aug 14, 2020

SELL
$7.4 - $14.64 $5.97 Million - $11.8 Million
-806,436 Reduced 20.56%
3,115,537 $26 Million
Q1 2020

May 15, 2020

BUY
$3.61 - $8.6 $11.4 Million - $27.1 Million
3,155,825 Added 411.91%
3,921,973 $30.1 Million
Q4 2019

Feb 14, 2020

SELL
$5.17 - $8.91 $5.74 Million - $9.9 Million
-1,111,000 Reduced 59.19%
766,148 $6.37 Million
Q3 2019

Nov 14, 2019

BUY
$7.38 - $12.25 $26,058 - $43,254
3,531 Added 0.19%
1,877,148 $13.9 Million
Q2 2019

Aug 14, 2019

BUY
$9.35 - $11.41 $6.32 Million - $7.71 Million
675,617 Added 56.4%
1,873,617 $21 Million
Q1 2019

May 15, 2019

BUY
$9.5 - $19.16 $11.4 Million - $23 Million
1,198,000 New
1,198,000 $12.9 Million
Q1 2018

May 07, 2018

SELL
$21.76 - $34.22 $24.5 Million - $38.5 Million
-1,124,483 Closed
0 $0
Q4 2017

Feb 14, 2018

SELL
$19.0 - $23.09 $21 Million - $25.5 Million
-1,106,415 Reduced 49.6%
1,124,483 $23.7 Million
Q3 2017

Nov 14, 2017

BUY
$13.53 - $18.17 $30.2 Million - $40.5 Million
2,230,898
2,230,898 $40.5 Million

Others Institutions Holding CTMX

About CytomX Therapeutics, Inc.


  • Ticker CTMX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 65,950,200
  • Market Cap $66M
  • Description
  • CytomX Therapeutics, Inc. operates as an oncology-focused biopharmaceutical company in the United States. The company develops antibody therapeutics based on its Probody technology platform for the treatment of cancer. The company's product candidates include CX-2009, an antibody drug conjugates (ADC) against CD166, which is in Phase II clinical...
More about CTMX
Track This Portfolio

Track Bvf Inc Portfolio

Follow Bvf Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Bvf Inc, based on Form 13F filings with the SEC.

News

Stay updated on Bvf Inc with notifications on news.